Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer

B. Doleschal; H. Taghizadeh; T. Lentner; J.m. Riedl; J. Granitzer; D. Morariu; J. Decker; K.j. Aichberger; G. Webersinke; P. Kirchweger; A. Petzer; H. Rumpold

doi:10.1016/j.esmoop.2023.102064

Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer

B. Doleschal^*, H. Taghizadeh, T. Lentner, J.m. Riedl, J. Granitzer, D. Morariu, J. Decker, K.j. Aichberger, G. Webersinke, P. Kirchweger, A. Petzer, H. Rumpold

^*Corresponding author for this work

Division of Internal Medicine 1 (University Hospital St. Pölten)

Research output: Journal article (peer-reviewed) › Journal article

Original language	English
Pages (from-to)	102064
Journal	ESMO Open
Volume	8
Issue number	6
DOIs	https://doi.org/10.1016/j.esmoop.2023.102064
Publication status	E-pub ahead of print - 16 Nov 2023

Access to Document

10.1016/j.esmoop.2023.102064Licence: CC BY-NC-ND

https://linkinghub.elsevier.com/retrieve/pii/S2059702923013054

Cite this

Doleschal, B., Taghizadeh, H., Lentner, T., Riedl, J. M., Granitzer, J., Morariu, D., Decker, J., Aichberger, K. J., Webersinke, G., Kirchweger, P., Petzer, A., & Rumpold, H. (2023). Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer. ESMO Open, 8(6), 102064. Advance online publication. https://doi.org/10.1016/j.esmoop.2023.102064

@article{7aa9dcbf24bd4e60890a24e931ae5124,

title = "Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer",

author = "B. Doleschal and H. Taghizadeh and T. Lentner and J.m. Riedl and J. Granitzer and D. Morariu and J. Decker and K.j. Aichberger and G. Webersinke and P. Kirchweger and A. Petzer and H. Rumpold",

year = "2023",

month = nov,

day = "16",

doi = "10.1016/j.esmoop.2023.102064",

language = "English",

volume = "8",

pages = "102064",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "Elsevier BV",

number = "6",

}

Doleschal, B, Taghizadeh, H , Lentner, T, Riedl, JM, Granitzer, J, Morariu, D, Decker, J, Aichberger, KJ, Webersinke, G, Kirchweger, P, Petzer, A & Rumpold, H 2023, 'Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer', ESMO Open, vol. 8, no. 6, pp. 102064. https://doi.org/10.1016/j.esmoop.2023.102064

TY - JOUR

T1 - Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer

AU - Doleschal, B.

AU - Taghizadeh, H.

AU - Lentner, T.

AU - Riedl, J.m.

AU - Granitzer, J.

AU - Morariu, D.

AU - Decker, J.

AU - Aichberger, K.j.

AU - Webersinke, G.

AU - Kirchweger, P.

AU - Petzer, A.

AU - Rumpold, H.

PY - 2023/11/16

Y1 - 2023/11/16

U2 - 10.1016/j.esmoop.2023.102064

DO - 10.1016/j.esmoop.2023.102064

M3 - Journal article

SN - 2059-7029

VL - 8

SP - 102064

JO - ESMO Open

JF - ESMO Open

IS - 6

ER -